1. Home
  2. IPGP vs ARQT Comparison

IPGP vs ARQT Comparison

Compare IPGP & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IPG Photonics Corporation

IPGP

IPG Photonics Corporation

HOLD

Current Price

$72.91

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$31.83

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPGP
ARQT
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
IPGP
ARQT
Price
$72.91
$31.83
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
★ $124.14
$39.13
AVG Volume (30 Days)
302.3K
★ 2.2M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 117.85
88.79
EPS
★ 0.16
0.03
Revenue
★ $1,003,777,000.00
$376,072,000.00
Revenue This Year
$11.84
$43.21
Revenue Next Year
$9.07
$29.18
P/E Ratio
★ $444.06
$1,045.67
Revenue Growth
2.73
★ 91.34
52 Week Low
$68.27
$19.30
52 Week High
$155.82
$33.30

Technical Indicators

Market Signals
Indicator
IPGP
ARQT
Relative Strength Index (RSI) 45.55 66.30
Support Level $69.41 $23.42
Resistance Level $81.08 N/A
Average True Range (ATR) 3.06 1.54
MACD -0.38 0.51
Stochastic Oscillator 40.02 82.43

Price Performance

Historical Comparison
IPGP
ARQT

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: